Toll-like receptors and TLR-mediated signaling: More questions than answers

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 5 30-5, 2004, Pages

  Pan, Zhixing K ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CALCIUM; CD14 ANTIGEN; CYTOKINE; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 6; LIPOARABINOMANNAN; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOTEICHOIC ACID; MANNAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PEPTIDOGLYCAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL RECEPTOR INTERLEUKIN 1 RECEPTOR DOMAIN CONTAINING ADAPTER PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; EDITORIAL; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; TRACHEA MUSCLE;

ANIMALS; BACTERIAL PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH; NF-KAPPA B; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRACHEA;

EID: 1942485320     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00381.2003     Document Type: Editorial

References (34)

1. Aderem A and Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787, 2000.
2. Anderson KV. Toll signaling pathways in the innate immune response. Curr Opin Immunol 12: 13-19, 2000.
3. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, and Knaus UG. Toll-like receptor 2-mediated NF-κB activation requires a Rac1-dependent pathway. Nat Immun 1: 533-540, 2000.
4. Belvin MP and Anderson KV. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 12: 393-416, 1996.
5. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, and Modlin RL. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-736, 1999.
6. Chen LY, Zuraw BL, Liu FT, Huang S, and Pan ZK. IL-1 receptor-associated kinase and low molecular weight GTPase RhoA signal molecules are required for bacterial lipopolysaccharide-induced cytokine gene transcription. J Immunol 169: 3934-3939, 2002.
7. Chen LY, Zuraw BL, Zhao M, Liu FT, Huang S, and Pan ZK. Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-κB activation in human peripheral blood monocytes. Am J Physiol Lung Cell Mol Physiol 284: L607-L613, 2003.
8. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S, and Cobb MH. New insights into the control of MAP kinase pathways. Exp Cell Res 253: 255-270, 1999.
9. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, and O'Neill LA. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83, 2001.
10. Horng T, Barton GM, and Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immun 2: 835-841, 2001.
11. Karin M and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18: 621-663, 2001.
12. Kawai T, Adachi O, Ogawa T, Takeda K, and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122, 1999.
13. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, Davis R, Flavell R, and Kollias G. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 20: 3760-3770, 2001.
14. Kopp EB and Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 11: 13-18, 1999.
15. Lee C-W, Chien C-S, and Yang C-M. Lipoteichoic acid-stimulated p42/p44 MAPK activation via Toll-like receptor 2 in tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 286: L921-L930, 2004.
16. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, and Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47: 185-201, 2000.
17. Leemans JC, Vervoordeldonk MJ, Florquin S, van Kessel KP, and van der Poll T. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am J Respir Crit Care Med 165: 1445-1450, 2002.
18. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, and Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973-983, 1996.
19. Lemjabbar H and Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med 8: 41-46, 2002.
20. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, and Clark AR. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor α mRNA stability. Mol Cell Biol 21: 6461-6469, 2001.
21. Martin-Blanco E. p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 22: 637-645, 2000.
22. Medzhitov R and Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9: 4-9, 1997.
23. Morath S, Geyer A, and Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 193: 393-397, 2001.
24. Muzio M, Natoli G, Saccani S, Levrero M, and Mantovani A. The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 187: 2097-2101, 1998.
25. Ono K and Han J. The p38 signal transduction pathway: activation and function. Cell Signal 12: 1-13, 2000.
26. Opitz B, Schroder NW, Spreitzer I, Michelsen KS, Kirschning CJ, Hallatschek W, Zahringer U, Hartung T, Gobel UB, and Schumann RR. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J Biol Chem 276: 22041-22047, 2001.
27. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
28. Rock FL, Hardiman G, Timans JC, Kastelein RA, and Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95: 588-593, 1998.
29. Schroder NW, Morath S, Alexander C, Hamann L, Hartung T, Zahringer U, Gobel UB, Weber JR, and Schumann RR. Lipoteichoic acid of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor-2, lipopolysaccharide-binding protein, and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278: 15587-15594, 2003.
30. Schwandner R, Dziarski R, Wesche H, Rothe M, and Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274: 17406-17409, 1999.
31. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, and Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451, 1999.
32. Vasudevan S and Peltz SW. Regulated ARE-mediated mRNA decay in Saccharomyces cerevisiae. Mol Cell 7: 1191-1200, 2001.
33. Widmann C, Gibson S, Jarpe MB, and Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180, 1999.
34. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, and Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163: 1-5, 1999.